NEWSKIN M48 Meeting in Orléans, France
30 Apr 25
On 22 March 2024, the NEWSKIN project consortium, composed of 34 partners, gathered in Orléans (France) to review the project’s
On 22 March 2024, the NEWSKIN project consortium, composed of 34 partners, gathered in Orléans (France) to review the project’s
On 29–30 May 2024, the HEATERNAL project consortium, composed of 11 partners, gathered at the University of Gent, in Gent
On 2–3 July 2024, the ECS4DRES project consortium, composed of 31 partners, met at Infineon Technologies AG in Neubiberg, Germany,
On 17-18 April 2024, the BATRAW consortium, composed of 17 partners, gathered at MTB Manufacturing facilities in Saint-Chef, France. The
From December 9th to 12th, 2024, the 17 partners of the BATRAW project gathered at the Centre for European Policy
The ALBATROSS project consortium, formed by 21 partners, gathered on 10–11 July 2024 at the Gipuzkoa Science and Technology Park
On April 1st and 2nd, 2025, the GeoS-TECHIS European project consortium held its 6-month follow-up meeting in Pontevedra, Spain. The
From March 26th to 28th, the RecAL project team and Leitat gathered in Thessaloniki to celebrate a year of progress
Illustration 1 Group picture of the PROMISERS team Terrassa, 21th March 2025 – Leitat, a European-accredited technological centre is coordinating
On March 11, 2025, the annual meeting of the LUPYPLAST project took place in Toledo. It was an inspiring and
Osteoarticular osteoarthritis is a chronic degenerative disease that affects the joints, particularly in older individuals, negatively impacting their quality of
On February 14, 2025, the kick-off meeting (KOM) of the VAGINEF project took place at the Vall d’Hebron Research Institute
On February 11–12, 2025, the partners of the REDWine project gathered at ALGAMA’s facilities in Paris for the M46 General
The Net-Fuels project partners met on November 13–14, 2024 in Graz (Austria) to assess progress in the production of carbon-negative
The biopharmaceutical company ONCOMATRYX Biopharma and Leitat are collaborating in the NEXTOM project, which aims to develop new Antibody Drug
The BIOMETHAVERSE consortium, made up of 22 partners, gathered in Barcelona from 27 to 29 November at Leitat’s facilities in
Phone. (+34) 937 882 300
